Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1605-1608

  Wu, Xifeng ^a,b,d   Zhao, Ying ^a,b   Honn, Susan E ^a   Tomlinson, Gail E ^c   Minna, John D ^c   Hong, Waun Ki ^a   Spitz, Margaret R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,8 DIHYDROXYBENZO[A]PYRENE 9,10 OXIDE; CARCINOGEN; TOBACCO SMOKE;

ADULT; AGED; ARTICLE; CHROMOSOME 3P; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLITE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; AGED; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; PILOT PROJECTS; RISK; SMOKING;

EID: 0032522646     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Davila, D. G., and Williams, D. E. The etiology of lung cancer. Mayo Clin. Proc., 68: 170-182, 1993.
2. Sellers, T. A., Potter, J. D., Bailey-Wilson, J. E., Rich, S. S., Rothschild, H., and Elsta, R. C. Lung cancer detection and prevention: evidence for an interaction between smoking and genetic predisposition. Cancer Res., 52: 2696-2697, 1992.
3. Phillips, D. H. Fifty years of benzo(a)pyrene. Nature (Lond.), 303: 468-472, 1983.
4. Wu, X., Gu, J., Hsu, T. C., Hong, W. K., Shi, H., and Spitz, M. R. Differential sensitivity to benzo[a]pyrene-diol-epoxide (BPDE) as a marker of lung cancer susceptibility. Proc. Am. Assoc. Cancer Res., 38: 618, 1997.
5. Wu, X. F., Hsu, T. C., Annegers, J. F., Amos, C. I., Fueger, J. J., and Spitz, M. R. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer patients. Cancer Res., 55: 557-561, 1995.
6. Whang-Peng, J., Kao, S. C., Lee, E. C., Bunn, P. A., Carney, D. N., Gazdar, A. F., and Minna, J. D. A specific chromosome defect associated with human small cell lung cancer. Science (Washington DC), 215: 181-185, 1982.
7. Kok, K., Hosfra, R., Pilz, A., van den Berg, A., Terpstra, P., Buys, C. H., and Carrit, B. A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin activating enzyme. Proc. Natl. Acad. Sci. USA, 90: 6071-6075, 1993.
8. Roche, J., Boldog, F., Robinson, M., Robinson, L., Varella-Garcia, M., Swanton, M., Waggoner, B., Fishel, R., Franklin, W., Gemmill, R., and Drabkin, H. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene, 12: 1289-1297, 1996.
9. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., Gregorio, L. D., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
10. Sozzi, G., Sard, L., De Gregorio, L., Marchetti, A., Musso, K., Buttitta, F., Tornielli, S., Pellegrini, S., Veronese, M. L., Manenti, G., Incarbone, M., Chella, A., Angeletti, C. A., Pastorino, U., Huebner, K., Bevilaqua, G., Pilotti, S., Croce, C. M., and Pierotti, M. A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res., 57: 2121-2123, 1997.
11. Hudmon, K. S., Honn, S. E., Jiang, H., Chamberlain, R. M., Xiang, W., Ferry, G., Gosbee, W., and Spitz, M. R. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol. Biomarkers Prev., 6: 565-572, 1997.
12. Wu, X., Delclos, G. L., Annegers, J. F., Bondy, M. L., Honn, S. E., Henry, B., Hsu, T. C., and Spitz, M. R. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 4: 583-588, 1995.
13. Spitz, M. R., Hoque, A., Trizna, Z., Schantz, S. P., Amos, C. I., King, T. M., Bondy, M. L., Hong, W. K., and Hsu, T. C. Mutagen sensitivity as a risk factor for second malignant tumors following upper aerodigestive tract malignancies. J. Natl. Cancer Inst. (Bethesda), 86: 1681-1684, 1994.
14. Spitz, M. R., Fueger, J. J., Beddingfield, N. A., Annegers, J. F., Hsu, T. C., Newell, G. R., and Schantz, S. P. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res., 49: 4626-4628, 1989.
15. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
16. Daly, M. C., Xiang, R. H., Buchhagen, D., Hensel, C. H., Garcia, D. K., Killary, A. M., Minna, J. D., and Naylor, S. L. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene, 8: 1721-1729, 1993.
17. Killary, A. M., Wolf, M. E., Giambemardi, T. A., and Naylor, S. L. Definition of a tumor suppressor locus within human chromosome 3p21-p22. Proc. Natl. Acad. Sci. USA, 89: 10877-10881, 1992.
18. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
19. Virgilio, L., Shuster, M., Gollin, S. M., Veronese, M. L., Ohta, M., Huebner, K., and Croce, C. M. FHIT gene alterations in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 93: 9770-9775, 1996.
20. Akihiko, G., Hagiwara, K., Ke, Y., Burke, L. M., Khan, M. A., Nagashima, M., Bennett, W. P., and Harris, C. C. FHIT mutations in human primary gastric cancer. Cancer Res., 57: 1435-1437, 1997.